Cargando…

Longitudinal validity of PET‐based staging of regional amyloid deposition

Positron emission tomography (PET)‐based staging of regional amyloid deposition has recently emerged as a promising tool for sensitive detection and stratification of pathology progression in Alzheimer's Disease (AD). Here we present an updated methodological framework for PET‐based amyloid sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jelistratova, Irina, Teipel, Stefan J., Grothe, Michel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502828/ https://www.ncbi.nlm.nih.gov/pubmed/32648624 http://dx.doi.org/10.1002/hbm.25121

Ejemplares similares

In vivo staging of regional amyloid deposition
por: Grothe, Michel J., et al.
Publicado: (2017)

In vivo staging of regional amyloid progression in healthy middle-aged to older people at risk of Alzheimer’s disease
por: Levin, Fedor, et al.
Publicado: (2021)

Association of PET‐based stages of amyloid deposition with neuropathological markers of Aβ pathology
por: Teipel, Stefan J., et al.
Publicado: (2020)

Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study
por: Sakr, Fatemah A., et al.
Publicado: (2019)

Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study
por: Sakr, Fatemah A., et al.
Publicado: (2022)

Molecular properties underlying regional vulnerability to Alzheimer’s disease pathology
por: Grothe, Michel J, et al.
Publicado: (2018)

Multitracer model for staging cortical amyloid deposition using PET imaging
por: Collij, Lyduine E., et al.
Publicado: (2020)

Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s disease: a longitudinal PET study
por: Ismail, Rola, et al.
Publicado: (2020)

Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
por: Levin, Fedor, et al.
Publicado: (2021)

Development and clinical validation of CT-based regional modified Centiloid method for amyloid PET
por: Kim, Soo-Jong, et al.
Publicado: (2022)

Longitudinal assessment of amyloid-beta deposition in initially amyloid-negative non-demented individuals with [11C]-PIB PET imaging
por: Hatashita, Shizuo, et al.
Publicado: (2021)

Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia
por: Salvadó, Gemma, et al.
Publicado: (2021)

Predicting amyloid PET and tau PET stages with plasma biomarkers
por: Jack, Clifford R, et al.
Publicado: (2023)

Gaussian Graphical Models Reveal Inter-Modal and Inter-Regional Conditional Dependencies of Brain Alterations in Alzheimer's Disease
por: Dyrba, Martin, et al.
Publicado: (2020)

Asymmetric amyloid deposition in preclinical Alzheimer’s disease: A PET study
por: Kjeldsen, Pernille L., et al.
Publicado: (2022)

HEARING IMPAIRMENT, COGNITIVE PERFORMANCE, AND BETA-AMYLOID DEPOSITION IN THE ARIC-PET AMYLOID IMAGING STUDY
por: Deal, Jennifer A, et al.
Publicado: (2019)

Metabolic and amyloid PET network reorganization in Alzheimer’s disease: differential patterns and partial volume effects
por: Gonzalez-Escamilla, Gabriel, et al.
Publicado: (2020)

Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach
por: Royse, Sarah K., et al.
Publicado: (2021)

Vestibular Function and Beta-Amyloid Deposition in the Baltimore Longitudinal Study of Aging
por: Kamil, Rebecca J., et al.
Publicado: (2018)

Sensory impairment and beta‐amyloid deposition in the Baltimore longitudinal study of aging
por: Yesantharao, Lekha, et al.
Publicado: (2023)

Clinical significance of focal ß-amyloid deposition measured by (18)F-flutemetamol PET
por: Kim, Si Eun, et al.
Publicado: (2020)

PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer’s disease progression in Down syndrome
por: Zammit, Matthew D., et al.
Publicado: (2021)

Early Detection of Aβ Deposition in the 5xFAD Mouse by Amyloid PET
por: Oh, Se Jong, et al.
Publicado: (2018)

Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease
por: Teipel, Stefan J., et al.
Publicado: (2020)

No association of cortical amyloid load and EEG connectivity in older people with subjective memory complaints
por: Teipel, Stefan, et al.
Publicado: (2017)

Estimation of amyloid distribution by [(18)F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition
por: Thal, Dietmar Rudolf, et al.
Publicado: (2018)

Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
por: Padilla, Concepcion, et al.
Publicado: (2022)

Sensory Impairment and Beta-Amyloid Deposition in the Baltimore Longitudinal Study of Aging
por: Armstrong, Nicole, et al.
Publicado: (2021)

The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment — Beyond classical regression
por: Teipel, Stefan J., et al.
Publicado: (2015)

Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors
por: Teipel, Stefan J., et al.
Publicado: (2018)

The effect of amyloid deposition on longitudinal resting-state functional connectivity in cognitively normal older adults
por: Lin, Chemin, et al.
Publicado: (2020)

Neuronal activity regulates the regional vulnerability to amyloid-β deposition
por: Bero, Adam W., et al.
Publicado: (2011)

Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives
por: Cotta Ramusino, Matteo, et al.
Publicado: (2021)

(18)F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition
por: Baratto, Lucia, et al.
Publicado: (2018)

Longitudinal Assessment of Amyloid-β Deposition by [18F]-Flutemetamol PET Imaging Compared With [11C]-PIB Across the Spectrum of Alzheimer’s Disease
por: Hatashita, Shizuo, et al.
Publicado: (2019)

Longitudinal [(18)F]FDG-PET/CT analysis of the glucose metabolism in ApoE-deficient mice
por: Kuhla, Angela, et al.
Publicado: (2020)

Amyloid beta plaque accumulation with longitudinal [18F]AZD4694 PET
por: Therriault, Joseph, et al.
Publicado: (2023)

APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study
por: Ramanan, Vijay K., et al.
Publicado: (2013)

PT569. Association between cerebral amyloid deposition and cognitive function in geriatric depression: pilot study using amyloid PET
por: Kim, Hye-Geum, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_usl5vteaoiutlfhd7vmruq7rad